This company offers a portable, wearable device that uses patented bioelectrical stimulation and targeted stem cell reactivation technology (SCRT) to treat hair loss. The device aims to counteract follicle miniaturization by restoring the body's natural physiological hair regeneration cycle without medication or surgery. Users can expect healthier, thicker hair growth within six months through a simple 30-minute daily treatment.
Funding
$2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
EFFounders
Product
Problem
Hair loss, or androgenetic alopecia, affects a significant portion of the population and can negatively impact self-esteem. Current treatments often involve pharmaceuticals or invasive procedures, which may present undesirable side effects or limited effectiveness.
Solution
Niostem offers a non-invasive, drug-free solution to combat hair loss using a wearable device that employs Stem Cell Reactivation Technology (SCRT). The device delivers low-level bioelectrical stimulation to the scalp, reactivating dormant hair follicle stem cells. This stimulation encourages the stem cells to convert into progenitor cells, which then fuel hair follicle growth, leading to thicker and healthier hair. The Niostem system includes a smart wearable device with integrated sensors and a companion mobile app for personalized stimulation, progress tracking, and adherence support.
Target Audience
The primary target audience includes individuals experiencing early to mid-stage androgenetic alopecia (Norwood scale 1-5) seeking a non-pharmaceutical, non-invasive solution to prevent hair loss and stimulate regrowth.
Features
- Wearable device delivering low-level bioelectrical stimulation to the scalp
- Stem Cell Reactivation Technology (SCRT) to reactivate dormant hair follicle stem cells
- Non-invasive and drug-free approach to hair regeneration
- Smart sensors integrated into the wearable device to ensure stable scalp-electrode connectivity
- Mobile app for device control, progress tracking, and session reminders
- Personalized stimulation settings via the mobile app
- Compatibility with Android 11+ and iOS 13+
- 2-year warranty in accordance with EU regulations